Workflow
饶毅:麦角硫因就是“假药”
Bei Ke Cai Jing·2025-06-05 13:10

Core Viewpoint - The article emphasizes that any substance lacking sufficient evidence to be approved as a genuine drug is considered a fake drug, and it highlights that ergothioneine is categorized as a "fake drug" [4]. Group 1: Drug Approval and Evidence - Genuine drugs require substantial evidence for approval from regulatory authorities, while those without such evidence are labeled as fake drugs [3][5]. - The article references the case of Viagra, which was approved after rigorous scientific research demonstrated its efficacy, contrasting it with ergothioneine, which lacks similar evidence [2][5]. Group 2: Ethical Concerns in Marketing - The promotion of ergothioneine is presented as an example of unethical marketing practices, where merchants prioritize sales over integrity [8]. - The article criticizes the use of unconventional marketing tactics, such as male nude performances, to sell fake drugs, indicating a moral decline in the health supplement industry [9][12]. Group 3: Consumer Responsibility - Consumers purchasing ergothioneine are portrayed as easily deceived, and the article advises against using such products as a means of showing filial piety, suggesting that genuine care involves spending quality time with loved ones instead [13][14].